HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christopher Power Selected Research

Central Nervous System Diseases (CNS Diseases)

1/2014Allopregnanolone and neuroinflammation: a focus on multiple sclerosis.
8/2008HIV infection of the central nervous system: clinical features and neuropathogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christopher Power Research Topics

Disease

31Neuroinflammatory Diseases
08/2022 - 02/2004
28Infections
12/2021 - 06/2003
23Acquired Immunodeficiency Syndrome (AIDS)
01/2021 - 11/2004
18Multiple Sclerosis
08/2022 - 03/2003
13HIV Infections (HIV Infection)
12/2023 - 10/2003
12Inflammation (Inflammations)
10/2022 - 03/2003
10Nervous System Diseases (Neurological Disorders)
04/2024 - 12/2004
9Demyelinating Diseases (Demyelinating Disease)
01/2024 - 02/2004
9Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2019 - 06/2005
7Lentivirus Infections
05/2014 - 07/2005
6Neurocognitive Disorders (Clerambault Syndrome)
11/2023 - 11/2015
6Encephalitis (Encephalitis, Rasmussen)
01/2023 - 03/2003
5Brain Diseases (Brain Disorder)
04/2024 - 06/2003
5Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 10/2007
5Gliosis
05/2017 - 01/2004
4Dementia (Dementias)
04/2024 - 06/2005
4Zika Virus Infection
01/2019 - 12/2016
3Coinfection
01/2020 - 04/2009
3Atrophy
11/2011 - 03/2006
3Peripheral Nervous System Diseases (PNS Diseases)
11/2011 - 10/2006
2Stroke (Strokes)
04/2024 - 02/2014
2Rupture
01/2024 - 08/2020
2Neuralgia (Stump Neuralgia)
01/2021 - 11/2010
2Cognitive Dysfunction
01/2021 - 10/2006
2Astrocytoma (Pilocytic Astrocytoma)
01/2021 - 05/2017
2Substance-Related Disorders (Drug Abuse)
01/2020 - 01/2016
2Neoplasms (Cancer)
09/2019 - 06/2005
2Alzheimer Disease (Alzheimer's Disease)
02/2014 - 10/2007
2Central Nervous System Diseases (CNS Diseases)
01/2014 - 08/2008
2Superinfection
04/2009 - 04/2005
2AIDS Dementia Complex
03/2007 - 08/2005
1Parkinsonian Disorders (Parkinsonism)
04/2024
1Seizures (Absence Seizure)
04/2024
1Parkinson Disease (Parkinson's Disease)
01/2022
1Huntington Disease (Huntington's Disease)
01/2022
1Shock
12/2021
1COVID-19
01/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2021

Drug/Important Bio-Agent (IBA)

17Proteins (Proteins, Gene)FDA Link
01/2021 - 06/2003
8InflammasomesIBA
08/2022 - 12/2013
7RNA (Ribonucleic Acid)IBA
04/2024 - 08/2005
7Antiviral Agents (Antivirals)IBA
01/2021 - 10/2016
7CytokinesIBA
10/2019 - 04/2005
6Peptide Hydrolases (Proteases)FDA Link
10/2019 - 01/2004
6MicroRNAs (MicroRNA)IBA
12/2018 - 06/2010
6Neuroprotective AgentsIBA
03/2018 - 09/2009
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2016 - 04/2005
5InterferonsIBA
11/2018 - 11/2010
5Messenger RNA (mRNA)IBA
11/2015 - 03/2003
5syncytinIBA
11/2011 - 10/2004
4CuprizoneIBA
01/2024 - 01/2021
4DNA (Deoxyribonucleic Acid)IBA
01/2023 - 01/2017
4Proteinase-Activated ReceptorsIBA
11/2011 - 01/2004
4Glycoproteins (Glycoprotein)IBA
11/2011 - 10/2004
3Biomarkers (Surrogate Marker)IBA
12/2018 - 02/2011
3NeurosteroidsIBA
10/2017 - 09/2011
3vpr Gene ProductsIBA
01/2017 - 09/2010
3ThrombinFDA Link
11/2015 - 03/2003
3Viral ProteinsIBA
06/2012 - 01/2006
3G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
11/2011 - 03/2003
2NucleosidesIBA
01/2021 - 01/2016
2belnacasanIBA
01/2021 - 01/2017
2NucleotidesIBA
01/2021 - 01/2016
2Caspase 3 (Caspase-3)IBA
01/2021 - 08/2020
2Free RadicalsIBA
10/2019 - 02/2011
2Matrix Metalloproteinases (MMPs)IBA
03/2018 - 06/2003
2Insulin (Novolin)FDA Link
01/2018 - 10/2016
2ChemokinesIBA
01/2018 - 10/2003
2Dehydroepiandrosterone (DHEA)IBA
10/2017 - 02/2013
2InterleukinsIBA
10/2017 - 11/2015
2EnzymesIBA
10/2017 - 09/2011
2AntigensIBA
01/2017 - 05/2013
2Protease Inhibitors (Protease Inhibitor)IBA
02/2016 - 05/2006
2PAR-1 ReceptorIBA
11/2015 - 03/2003
2Pregnanolone (Allopregnanolone)IBA
01/2014 - 09/2011
2Carisoprodol (Soma)FDA LinkGeneric
11/2011 - 03/2006
2CalciumIBA
11/2011 - 11/2010
2Peptides (Polypeptides)IBA
11/2011 - 03/2003
2AntioxidantsIBA
02/2011 - 10/2004
2Interleukin-1beta (Interleukin 1 beta)IBA
05/2010 - 05/2003
2Interleukin-4 (Interleukin 4)IBA
05/2010 - 10/2007
2Purinergic P1 Receptors (Adenosine Receptor)IBA
03/2008 - 02/2004
2Glial Fibrillary Acidic ProteinIBA
10/2007 - 07/2007
2Didanosine (Videx)FDA LinkGeneric
08/2007 - 05/2006
2LigandsIBA
06/2005 - 01/2004
1GasderminsIBA
01/2024
1CaspasesIBA
11/2023
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2022
14-phenylbutyric acid (Buphenyl)FDA Link
08/2022
14-phenylbutylamineIBA
08/2022
1GangliosidesIBA
01/2022
1Viral RNAIBA
12/2021
1NickelIBA
01/2021
1Glucose (Dextrose)FDA LinkGeneric
01/2021
1Adenosine Triphosphate (ATP)IBA
08/2020
1NigericinIBA
08/2020

Therapy/Procedure

17Therapeutics
11/2023 - 04/2005
9Highly Active Antiretroviral Therapy (HAART)
01/2018 - 08/2005
5Art Therapy
12/2023 - 10/2017
3Polypharmacy
01/2021 - 01/2016